How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: An international multidisciplinary team

Written on behalf of AME Lung Cancer Cooperative Group

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)3883-3890
Number of pages8
JournalJournal of Thoracic Disease
Volume10
Issue number6
DOIs
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this